NCT01172275View on ClinicalTrials.gov

N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

February 13, 2017

Study Completion Date

February 15, 2018

Conditions
Obsessive-Compulsive Disorder
Interventions
DRUG

N-Acetylcysteine

1 900mg tablet once a day for 1 week, then 1 900mg tablet twice a day for 1 week and then 1 900mg tablet three times a day for the remaining 10 weeks of the trial.

OTHER

Placebo

1 900mg tablet once a day for 1 week, then 1 900mg tablet twice a day for 1 week and then 1 900mg tablet three times a day for the remaining 10 weeks of the trial. Children receiving placebo will be offered the active intervention after the double-blind portion of the trial.

Trial Locations (1)

06520

Yale Child Study Center, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT01172275 - N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder | Biotech Hunter | Biotech Hunter